Background: Cirrhotic patients have been reported to have leukocyte impaired function as
well as a high incidence of infectious diseases. Granulocyte-macrophage colony-stimulating …

Results In the jaundice group neutrophil, lymphocyte and leukocyte counts were found to be
significantly lower compared to the other groups (P< 0.005). interferon-alpha and CD levels …

Leucopenia is often observed in patients with liver cirrhosis. We measured levels of serum
granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) in patients with liver cirrhosis …

In patients with end-stage liver disease complicated with hypersplenism, neutropenia and
thrombocytopenia are risk factors for systemic sepsis and spontaneous bleeding …

Objective: To evaluate the in vitro effects of granulocyte colony-stimulating factor (G-CSF) on
function of neutrophils in acute liver failure (ALF). Methods: Neutrophil functions (superoxide …

We investigated the serum level of macrophage colony stimulating factor in acute and
chronic liver disease. Levels of macrophage colony stimulating factor (mean±SD, ng/ml) …

Objectives: Neutrophil function is defective in acute liver failure (ALF) and the in vitro ability
of granulocyte colonystimulating factor (G-CSF) to reverse these defects has been reported …

Abstract Objective and Design: An important principle for the beneficial effects of granulocyte
colony-stimulating factor (G-CSF), a central mediator in the endogenous host response, is …

Acute liver failure (ALF) as well as acute-on-chronic liver failure (ACLF) in patients with pre-
existing chronic liver disease are defined by rapid deterioration of liver function in …

Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony-
stimulating factor in humans. Colony-stimulating factors are growth factors which induce …